WeShare (Ryan Purdy) speaks to Dr Saif Ahmad, cancer clinician and co-founder of NeutroCheck. NeutroCheck is a Cambridge based healthcare start-up developing novel lateral flow technologies to enable detection of blood cells (neutrophils) from point-of-care finger-prick blood samples. The NeutroCheck device is aimed at identifying cancer chemotherapy patients at risk of life-threatening neutropenic sepsis (infection while neutrophils, or white blood cell levels, are low). This low-cost portable device has the potential to prevent over 50,000 A&E visits each year in the UK, saving healthcare providers such as the NHS tens of millions of pounds, whilst preventing antibiotic resistance, improving patient care and clinical outcomes. NeutroCheck website (https://www.neutrocheck.com/) | WeShare Twitter@WeShareHlthcare | Email: email@example.com | Visit WeShare.Healthcare to share innovation now!